Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury

INTRODUCTION: The clinical course of coronavirus 2019 (COVID-19) is heterogeneous, ranging from mild to severe multiorgan failure and death. In this study, we analyzed cell-free DNA (cfDNA) as a biomarker of injury to define the sources of tissue injury that contribute to such different trajectories...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCI Insight
Egile Nagusiak: Andargie, Temesgen E., Tsuji, Naoko, Seifuddin, Fayaz, Jang, Moon Kyoo, Yuen, Peter S.T., Kong, Hyesik, Tunc, Ilker, Singh, Komudi, Charya, Ananth, Wilkins, Kenneth, Nathan, Steven, Cox, Andrea, Pirooznia, Mehdi, Star, Robert A., Agbor-Enoh, Sean
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2021
Gaiak:
Clinical Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119224/
https://ncbi.nlm.nih.gov/pubmed/33651717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.147610
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak